Tichenor Ventures
9
47M
4
1
0.56
3
- Stages of investment
- Areas of investment
Summary
The main office of represented VC is situated in the Dallas. The company was established in North America in United States.
The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2019. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2010. This Tichenor Ventures works on 14 percentage points more the average amount of lead investments comparing to the other organizations.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Tichenor Ventures, startups are often financed by The Column Group, Prospect Venture Partners, Rho Ventures. The meaningful sponsors for the fund in investment in the same round are The Column Group, Prospect Venture Partners, Auven Therapeutics. In the next rounds fund is usually obtained by Topspin Partners, HBM Healthcare Investments AG, The Column Group.
Among the most popular portfolio startups of the fund, we may highlight NGM Biopharmaceuticals, Kolltan Pharmaceuticals. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical, Therapeutics. The fund has no exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 1
- Exits
- 3
- Follow on index
- 0.56
- Investments by industry
- Biotechnology (8)
- Pharmaceutical (6)
- Medical (6)
- Genetics (3)
- Biopharma (3) Show 3 more
- Investments by region
-
- United States (9)
- Peak activity year
- 2010
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 208M
- Group Appearance index
- 1.00
- Avg. company exit year
- 9
- Avg. multiplicator
- 0.60
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| OS Therapies | 20 Apr 2021 | Health Care, Pharmaceutical, Therapeutics | Early Stage Venture | 6M | United States, Virginia |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.